Funder
Research Priming Fund (University of York)
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference23 articles.
1. Mease PJ, Antoni CE (2005) Psoriatic arthritis treatment: biological response modifiers. Ann Rheum Dis 64(suppl 2):ii78–ii82
2. Rodgers M, Epstein D, Bojke L et al (2010) Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technol Assess 15(10):1–329
3. Lu CY, Williams K, Day R (2008) Access to biologic medicines for the treatment of rheumatic diseases: lessons from Australia. Int J Rheum Dis 11(1):11–14
4. Rocchi A, Miller E, Hopkins RB, Goeree R (2012) Common drug review recommendations. PharmacoEconomics 30(3):229–246
5. Drummond MF, Schwartz JS, Jönsson B et al (2008) Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care 24(03):244–258
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献